AP
Alcinous Pharmaceuticals
Shutdownalcinouspharmaceuticals.com
Website unreachable since Oct 16, 2026
The startup develops therapeutics that modulate the activity of specific protein targets associated with cancer and other diseases. By enhancing treatment efficacy and minimizing toxicity, their therapies aim to improve patient outcomes in oncology.
- Biotechnology
Updated 21 months ago
Funding
Raised to date
$600KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops therapeutics that modulate the activity of specific protein targets associated with cancer and other diseases. By enhancing treatment efficacy and minimizing toxicity, their therapies aim to improve patient outcomes in oncology.